Resultados de la búsqueda 71-80 de 3714 para anti-TNF drugs

1. Neurología - Ensayos clínicos - Mayo Clinic

   Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous ...

2. Neurología - Ensayos clínicos - Mayo Clinic

   Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous ...

3. Untitled

   Page 1.

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... drug resistance/response profile will be a major focus of this aim. The second aim is to conduct high-throughput testing of various drugs (e.g., virotherapy ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... drug resistance/response profile will be a major focus of this aim. The second aim is to conduct high-throughput testing of various drugs (e.g., virotherapy ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... drug resistance/response profile will be a major focus of this aim. The second aim is to conduct high-throughput testing of various drugs (e.g., virotherapy ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to test drug enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC) ...

8. Neurología - Ensayos clínicos - Mayo Clinic

   Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous ...

9. Neurología - Ensayos clínicos - Mayo Clinic

   Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous ...

10. Neurología - Ensayos clínicos - Mayo Clinic

    Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous ...